<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Monogenic forms of hyperinsulinism&lt;sup&gt;[1-9]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Monogenic forms of hyperinsulinism<sup>[1-9]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Monogenic forms of hyperinsulinism<sup>[1-9]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="14%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Type</td> <td class="subtitle1">Gene</td> <td class="subtitle1">Locus</td> <td class="subtitle1">Inheritance</td> <td class="subtitle1">Diazoxide-responsive</td> <td class="subtitle1">Features</td> </tr> <tr> <td rowspan="4"><span style="white-space: nowrap;">K<sub>ATP</sub>-HI<sup>[1-2]</sup></span></td> <td rowspan="4"><em><a href="https://omim.org/entry/600509" target="_blank">ABCC8</a></em>, <em><a href="https://omim.org/entry/600937" target="_blank">KCNJ11</a></em></td> <td rowspan="4">11p15</td> <td>Recessive, biallelic</td> <td>No</td> <td> <p>Diffuse histology</p> LGA, protein-induced hypoglycemia, high GIR requirement</td> </tr> <tr> <td>Recessive, monoallelic*</td> <td>No</td> <td> <p><strong>Focal histology</strong></p> Protein-induced hypoglycemia, approximately 50% LGA, moderate-high GIR requirement</td> </tr> <tr> <td>Dominant</td> <td>No</td> <td> <p>Diffuse histology</p> Clinically indistinguishable from recessive forms</td> </tr> <tr> <td>Dominant</td> <td>Yes</td> <td> <p>Diffuse histology</p> Milder phenotype with less severe hypoglycemia, lower GIR requirement, protein-induced hypoglycemia</td> </tr> <tr class="highlight_lght_gray_text"> <td><span style="white-space: nowrap;"><a href="https://omim.org/entry/606762" target="_blank">GDH-HI</a><sup>[3]</sup></span></td> <td><em><a href="https://omim.org/entry/138130" target="_blank">GLUD1</a></em></td> <td>10q23</td> <td>Dominant, de novo</td> <td>Yes</td> <td>Protein-induced hypoglycemia, elevated ammonia, seizures, learning disabilities</td> </tr> <tr> <td><span style="white-space: nowrap;"><a href="https://omim.org/entry/602485" target="_blank">GCK-HI</a><sup>[4]</sup></span></td> <td><em><a href="https://omim.org/entry/138079" target="_blank">GCK</a></em></td> <td>7p13</td> <td>Dominant, de novo</td> <td>Variable</td> <td>Wide spectrum of severity and age at presentation</td> </tr> <tr class="highlight_lght_gray_text"> <td><span style="white-space: nowrap;">HNF4A-HI<sup>[5]</sup></span></td> <td><em><a href="https://omim.org/entry/600281" target="_blank">HNF4A</a></em></td> <td>20q13</td> <td>Dominant</td> <td>Yes</td> <td>LGA, risk for diabetes in adolescence or adulthood</td> </tr> <tr> <td><span style="white-space: nowrap;">HNF1A-HI<sup>[6]</sup></span></td> <td><em><a href="https://omim.org/entry/142410" target="_blank">HNF1A</a></em></td> <td>12q24</td> <td>Dominant</td> <td>Yes</td> <td>Risk for diabetes in adolescence or adulthood</td> </tr> <tr class="highlight_lght_gray_text"> <td><span style="white-space: nowrap;"><a href="https://omim.org/entry/609975" target="_blank">SCHAD-HI</a><sup>[7]</sup></span></td> <td><em><a href="https://omim.org/entry/601609" target="_blank">HADH</a></em></td> <td>4q25</td> <td>Recessive</td> <td>Yes</td> <td>Protein-induced hypoglycemia, abnormal acylcarnitine profile and urine organic acids</td> </tr> <tr> <td><span style="white-space: nowrap;">UCP2-HI<sup>[8]</sup></span></td> <td><em><a href="https://omim.org/entry/601693" target="_blank">UCP2</a></em></td> <td>11q13</td> <td>Dominant</td> <td>Yes</td> <td>Mild hypoglycemia</td> </tr> <tr class="highlight_lght_gray_text"> <td><span style="white-space: nowrap;"><a href="https://omim.org/entry/610021" target="_blank">MCT1-HI</a><sup>[9]</sup></span></td> <td><em><a href="https://omim.org/entry/600682" target="_blank">SCL16A1</a></em></td> <td>1p13</td> <td>Dominant</td> <td>Variable</td> <td>Hypoglycemia in response to anaerobic exercise</td> </tr> <tr> <td><span style="white-space: nowrap;">HK1-HI<sup>[10]</sup></span></td> <td><em><a href="https://www.omim.org/entry/142600">HK1</a></em></td> <td>10q22</td> <td>Dominant</td> <td>Variable</td> <td>Normal birth weight</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>K<sub>ATP</sub>: adenosine triphosphate-sensitive potassium channel;
    HI: hyperinsulinism;
    LGA: large for gestational age;
    GIR: glucose infusion rate;
    GDH: glutamate dehydrogenase-related hyperinsulinism;
    GCK: glucokinase;
    HNF4A: hepatocyte nuclear factor 4-alpha;
    HNF1A: hepatocyte nuclear factor 1-alpha;
    SCHAD: short-chain 3-hydroxyacyl-CoA dehydrogenase;
    HADH: 3-hydroxyacyl-coenzyme A dehydrogenase;
    UCP2: uncoupling protein 2;
    MCT1: monocarboxylic acid transporter 1.</p>
    
    * Paternally inherited recessive mutation with somatic loss of maternal 11p15 region, resulting in paternal isodisomy.</div><div class="graphic_reference">References:
    <ol>
<li>Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268:426.</li>
<li>Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Human molecular genetics 1996; 5:1809.</li>
<li>Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998; 338:1352.</li>
<li>Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998; 338:226.</li>
<li>Pearson ER, Boj SF, Steele AM, et al. Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene. PLoS Medicine 2007; 4:e118.</li>
<li>Stanescu DE, Hughes N, Kaplan B, et al. Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 2012; 97:E2026.</li>
<li>Li C, Chen P, Palladino A, et al. Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem 2010; 285:31806.</li>
<li>Gonz√°lez-Barroso MM, Giurgea I, Bouillaud F, et al. Mutations in UCP2 in Congenital Hyperinsulinism Reveal a Role for Regulation of Insulin Secretion. PLoS ONE 2008; 3:e3850.</li>
<li>Meissner T, Otonkoski T, Feneberg R, et al. Exercise induced hypoglycaemic hyperinsulinism. Arch Dis Child 2001; 84:254.</li>
<li>Wakeling MN, Owens NDL, Hopkinson JR, et al. Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism. Nat Genet 2022; 54:1615.</li>
</ol></div><div id="graphicVersion">Graphic 127861 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
